Carole Spangler Vaughn

Preventing nerve damage from chemotherapy


Dr. Carole Spangler Vaughn has a Ph.D. in Biophysics (Johns Hopkins University) and an MBA (University of Washington). She has spent over 25 years in the life science industry, mostly at start-ups, bringing oncology products to market. Her passion for Eisana was borne out of her personal frustration as a cancer patient, with a lack of patient-centric solutions to prevent side effects from treatment.


Preventing nerve damage from chemotherapy


Medical DevicesHealthcareHardwareAging & Elderly CareAngel InvestorsB2CDirect SalesFundraisingHospitals & Heathcare OrganizationsPrototypesSeedSocial EntrepreneurshipSocial Impact
Pitch is a Capital Factory product. © Capital Factory 2024. Privacy policy.